aTYR PHARMA INC Amortization of Debt Discount (Premium)
aTYR PHARMA INC (ATYR) reported Amortization of Debt Discount (Premium) of -$37.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2017-05-11
- aTYR PHARMA INC amortization of debt discount (premium) for the quarter ending 2017-03-31 was -$37.00K, a 168.52% decline year-over-year.
- aTYR PHARMA INC amortization of debt discount (premium) for the quarter ending 2016-12-31 was $43.00K, a 27.12% decline year-over-year.
- aTYR PHARMA INC amortization of debt discount (premium) for the quarter ending 2016-09-30 was $33.00K, a 52.86% decline year-over-year.
- aTYR PHARMA INC amortization of debt discount (premium) for the quarter ending 2016-06-30 was $43.00K, a 7.50% increase year-over-year.
- aTYR PHARMA INC amortization of debt discount (premium) for fiscal 2016 was $173.00K, a 41.75% decline from fiscal 2015.
- aTYR PHARMA INC amortization of debt discount (premium) for fiscal 2015 was $297.00K, a 30.28% decline from fiscal 2014.
- aTYR PHARMA INC amortization of debt discount (premium) for fiscal 2014 was $426.00K, a 101.90% increase from fiscal 2013.
- aTYR PHARMA INC amortization of debt discount (premium) for fiscal 2013 was $211.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$37.00K 10-Q · filed 2017-05-11 | $6.00K derived: sum of 2 quarters · filed 2017-05-11 | $39.00K derived: sum of 3 quarters · filed 2017-05-11 | $82.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $76.00K derived: sum of 2 quarters · filed 2017-03-16 | $119.00K derived: sum of 3 quarters · filed 2017-03-16 | $173.00K 10-K · filed 2017-03-16 |
| 2016-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $76.00K derived: sum of 2 quarters · filed 2016-11-14 | $130.00K 10-Q · filed 2016-11-14 | $189.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-06-30 | $43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $97.00K 10-Q · filed 2016-08-10 | $156.00K derived: sum of 3 quarters · filed 2017-05-11 | $226.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-03-31 | $54.00K 10-Q · filed 2017-05-11 | $113.00K derived: sum of 2 quarters · filed 2017-05-11 | $183.00K derived: sum of 3 quarters · filed 2017-05-11 | $223.00K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $129.00K derived: sum of 2 quarters · filed 2017-03-16 | $169.00K derived: sum of 3 quarters · filed 2017-03-16 | $297.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $110.00K derived: sum of 2 quarters · filed 2016-11-14 | $238.00K 10-Q · filed 2016-11-14 | $369.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $168.00K 10-Q · filed 2016-08-10 | $299.00K derived: sum of 3 quarters · filed 2017-03-16 | $439.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $128.00K 10-Q · filed 2016-05-11 | $259.00K derived: sum of 2 quarters · filed 2017-03-16 | $399.00K derived: sum of 3 quarters · filed 2017-03-16 | $484.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $271.00K derived: sum of 2 quarters · filed 2017-03-16 | $356.00K derived: sum of 3 quarters · filed 2017-03-16 | $426.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $225.00K derived: sum of 2 quarters · filed 2015-11-10 | $295.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $155.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $70.00K 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | $211.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |